Research ArticleBasic Science Investigations
Imaging Tumor Burden in the Brain with 89Zr-Transferrin
Michael J. Evans, Jason P. Holland, Samuel L. Rice, Michael G. Doran, Sarah M. Cheal, Carl Campos, Sean D. Carlin, Ingo K. Mellinghoff, Charles L. Sawyers and Jason S. Lewis
Journal of Nuclear Medicine January 2013, 54 (1) 90-95; DOI: https://doi.org/10.2967/jnumed.112.109777
Michael J. Evans
1Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York
Jason P. Holland
2Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York
Samuel L. Rice
2Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York
Michael G. Doran
2Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York
Sarah M. Cheal
2Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York
Carl Campos
1Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York
Sean D. Carlin
2Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York
Ingo K. Mellinghoff
1Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York
Charles L. Sawyers
1Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York
3Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, New York
Jason S. Lewis
2Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York
4Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, New York; and
5Radiochemistry and Imaging Sciences Service, Memorial Sloan-Kettering Cancer Center, New York, New York
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 1
January 1, 2013
Imaging Tumor Burden in the Brain with 89Zr-Transferrin
Michael J. Evans, Jason P. Holland, Samuel L. Rice, Michael G. Doran, Sarah M. Cheal, Carl Campos, Sean D. Carlin, Ingo K. Mellinghoff, Charles L. Sawyers, Jason S. Lewis
Journal of Nuclear Medicine Jan 2013, 54 (1) 90-95; DOI: 10.2967/jnumed.112.109777
Imaging Tumor Burden in the Brain with 89Zr-Transferrin
Michael J. Evans, Jason P. Holland, Samuel L. Rice, Michael G. Doran, Sarah M. Cheal, Carl Campos, Sean D. Carlin, Ingo K. Mellinghoff, Charles L. Sawyers, Jason S. Lewis
Journal of Nuclear Medicine Jan 2013, 54 (1) 90-95; DOI: 10.2967/jnumed.112.109777
Jump to section
Related Articles
Cited By...
- A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer
- An Overview of PET Radiochemistry, Part 2: Radiometals
- Noninvasive 89Zr-Transferrin PET Shows Improved Tumor Targeting Compared with 18F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer
- Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer
- Noninvasive Measurement of mTORC1 Signaling with 89Zr-Transferrin